Saint Luke's Newsroom
Sep. 1, 2023

FOX4: Saint Luke's Expands Hospital In Your Home Program to Serve Kansas Patients
Saint Luke's has expanded its Hospital In Your Home program, now available to Saint Luke's South Hospital and residents of Kansas.
Sep. 1, 2023

The New England Journal of Medicine Podcast: Obesity and Heart Failure
The NEJM Podcast looks at obesity and how it’s been neglected as a key to diagnosing and treating major diseases, including heart failure.
Aug. 31, 2023

KMBC: Kansas City Current Players Visit Saint Luke's Hospital Cancer Patients for Support

Leading up to the KC Kicks Cancer match, the players talked with patients about their journey and the importance of preventive screenings.
Aug. 30, 2023

KSHB: What KC Area Doctors Want You to Know About Eris, the Latest COVID-19 Variant
KSHB talked to Dr. Sarah Boyd about what people should know about the new variant of COVID-19.
Aug. 28, 2023

New York Times: Obesity Treatment Relieves Heart Failure Symptoms, Drugmaker’s Study Finds
The drug Wegovy eased issues for people with a type of heart problem, adding to the treatment’s benefits beyond weight loss.
Aug. 28, 2023

Nature Medicine: Semaglutide in HFpEF Across Obesity Class and by Body Weight Reduction: a Prespecified Analysis of the STEP-HFpEF Trial
In the STEP-HFpEF trial, semaglutide improved symptoms, physical limitations and exercise function and reduced body weight in patients with obesity phenotype of heart failure and preserved ejection fraction (HFpEF).
Aug. 26, 2023

CBS Evening News: Study Shows Wegovy May Reduce Risk of Heart Failure
The study shows that the diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial.
Aug. 26, 2023

Good Morning America: New Study Highlights Benefits to Weight Loss Drugs
Semaglutide, the active ingredient on weight loss drugs Wegovy and Ozempic, shows evidence that the drug may also help reduce the risks of heart disease.
Aug. 25, 2023

MEDIA COVERAGE: Obesity Medication Proves Effective in Treating Patients with Heart Failure
STEP-HFpEF trial findings were presented during the opening late breaking clinical trial session at the European Society of Cardiology Congress in Amsterdam, Netherlands.